The transaction started out as a hostile
takeover bid, with Aurora entering into a lock - up agreement with four major CanniMed shareholders.CanniMed's management retaliated by adopting a tactical shareholder rights plan, which was in turn challenged in court (and ultimately stuck down as an improper
defensive tactic).